Myelin is better preserved in TBI mice following LM22A-4 treatment. Fletcher et al., (2021) Exp Neurol. |
A study led by Dr Bridgette Semple in the Central Clinical School’s Department of Neuroscience, has demonstrated that treatment with a novel compound was able to protect the brain from degeneration after an early-life brain injury.